RIMKLA and Hyperinsulinemia: Under obese condition, hyperlipidemia and hyperinsulinemia repress RIMKLA to impair BHMT1 activity and elevate Hcy level, which activates AP1 to induce the transcriptions of FASn and CD36, stimulating de novo lipid synthesis and uptake.